Advarra, the market leader in regulatory reviews and a leading provider of clinical research technology, today announced the ...

Mayo Clinic researchers have developed a new way to predict whether existing drugs could be repurposed to treat heart failure ...

In this video interview, Umesh Chaudhari, executive medical director and global program head of the C5 programs at Regeneron, ...

The Study Design and Data Analysis support group at USF’s College of Public Health (COPH), that’s who. Known as the SDDA, the ...

The CORE-MD (Coordinating Research and Evidence for high-risk Medical Devices) consortium has published new consensus ...

"We are excited to see Pfizer advancing MesoC2 into clinical development rapidly, highlighting the potential of Nona's Harbour Mice® and integrated ADC platforms to deliver innovative cancer therapies ...

Clinical trial participants now expect clinical tools to match the usability of the digital tools they use every day.

Invivyd (IVVD) announced that the SPEAR Study Group has issued their consensus recommendation for a clinical study design to evaluate the effects ...

A majority of cancer drugs approved in the US during 2019-2022 had “clinical trial uncertainties,” research suggests.

HAS COMMENCED RECRUITMENT IN THIS 36 PARTICIPANT STUDY PHILADELPHIA, PENNSYLVANIA / ACCESS Newswire / September 8, 2025 / ...

A large UK-based retrospective cohort study found that initiating metformin within 90 days of COVID-19 diagnosis reduced the ...

According to ESC, these recommendations respond directly to a request from the European Commission to provide expert advice ...